Toho Holdings Co Ltd - Company Profile
Powered by 
All the data and insights you need on Toho Holdings Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Toho Holdings Co Ltd Strategy Report
- Understand Toho Holdings Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Toho Holdings Co Ltd (Toho) is a wholesaler of pharmaceutical products. It offers pharmaceutical wholesaling, dispensing pharmacy, and site management organization (SMO) solutions. The company provides reagents, prescription pharmaceuticals, and medical devices to clinics, hospitals, and dispensing pharmacies. Toho conducts various studies with and assists dispensing pharmacies. The company assists medical establishments including medical institutions and private clinics with clinical trial programs. It is also involved in the development, manufacture and sales of prescription pharmaceuticals focused on generic drugs. In addition, the company offers medical support and consulting, and reagent businesses for start-ups. Toho is headquartered in Setagaya, Tokyo, Japan.
Headquarters
Japan
Address
5-2-1, Daizawa, Setagaya-Ku, Tokyo, 155-8655
Website
www.tohohd.co.jp
Telephone
81 3 34197811
No of Employees
7,699
Industry
Wholesale
Ticker Symbol & Exchange
8129 (TYO)
Revenue (2023)
$10.3B
9.7%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
1.9%
(2023 vs 2022)
Market Cap*
$1.8B
Net Profit Margin (2023)
XYZ
-7.6%
(2023 vs 2022)
* As of and is in US$
Toho Holdings Co Ltd premium industry data and analytics
Products and Services
| Services |
|---|
| Wholesaling Pharmaceuticals: |
| Customer support system |
| Logistics system |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | New Products/Services | In June, the company's subsidiary Kyosomirai Pharma launched 1 ingredient / 3 products of generic drugs. |
| 2023 | Contracts/Agreements | In February, the company and National Institute of Advanced Industrial Science and Technology agreed to establish a collaborative research laboratory within the AIST Tsukuba Center. |
| 2022 | New Products/Services | In December, the company's subsidiary, Kyosomirai Pharma launched 1 ingredient / 2 products of generic drugs. |
Competitor Comparison
| Key Parameters | Toho Holdings Co Ltd | MediPal Holdings Corp | Alfresa Holdings Corp | Suzuken Co Ltd | Shionogi & Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Setagaya-Ku | Chuo-Ku | Chiyoda-Ku | Nagoya-Shi | Osaka-Shi |
| State/Province | Tokyo | Tokyo | Tokyo | Aichi | Osaka |
| No. of Employees | 7,699 | 12,795 | 11,772 | 13,429 | 5,680 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Norio Hamada | Chief Executive Officer; Chairman | Executive Board | 2017 | - |
| Atsushi Udoh | Chief Executive Officer; Director | Executive Board | - | - |
| Hiromi Edahiro | Director; Chief Financial Officer | Executive Board | - | - |
| Akio Nakashima | Director; President | Executive Board | 2023 | - |
| Mami Tada | General Manger, Regulatory Information Department, Toho Pharmaceutical Co., Ltd., Regulatory Affairs; Director; Office Manager, Division and Quality Assurance | Executive Board | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward